Some of the available studies have reported that the levels of S100A9 are significantly elevated in BALF of patients with pulmonary involvement in systemic sclerosis.[76–79] However, other studies have demonstrated that the levels of S100A9 in BALF of patients with pulmonary involvement in systemic sclerosis did not differ from healthy controls. Here, S100A9 is linked to systemic sclerosis.